menu
    • menu

    Company profile for ImmuneCyte Life Sciences

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ImmuneCyte is a joint venture between Healthbanks Biotech and ThermoGenesis. Healthbanks Biotech, established in 2001 and headquartered in Irvine, CA, is a dedicated to innovation and quality insurances in cell banking. ThermoGenesis (Nasdaq:KOOL), founded in 1986 in Sacramento, CA, is a major shareholder of the company. ThermoGenesis has pioneered in the field of cell banking, cell processing, and cell therapies. Its automate...
    ImmuneCyte is a joint venture between Healthbanks Biotech and ThermoGenesis. Healthbanks Biotech, established in 2001 and headquartered in Irvine, CA, is a dedicated to innovation and quality insurances in cell banking. ThermoGenesis (Nasdaq:KOOL), founded in 1986 in Sacramento, CA, is a major shareholder of the company. ThermoGenesis has pioneered in the field of cell banking, cell processing, and cell therapies. Its automated cell processing platform is one of the world’s most advanced automated technology for the cell banking industry. More than 1,000,000 automated processing procedures have been performed worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmuneCyte Life SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    185 Technology Dr. #150 Irvine, CA 92618
    Telephone
    Telephone
    1-833-604-0432
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://immunecyte.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CyteImmune

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ThermoGenesis & ImmuneCyte Joint Venture Develp Convalescent Plasma & Antibody
    ThermoGenesis & ImmuneCyte Joint Venture Develp Convalescent Plasma & Antibody

    24 Apr 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/thermogenesis-and-immunecyte-joint-venture-developing-several-convalescent-plasma-and-antibody-therapeutic-approaches-against-covid-19-featured-on-fox40-and-other-local-news-outlets-301046692.html

    PR NEWSWIRE
    24 Apr 2020
    Share Share
    ThermoGenesis Announces Its ImmuneCyte Joint Venture Acquires Key Technologies
    ThermoGenesis Announces Its ImmuneCyte Joint Venture Acquires Key Technologies

    13 Apr 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/thermogenesis-announces-its-immunecyte-joint-venture-acquires-key-technologies-to-develop-fully-human-polyclonal-and-monoclonal-antibody-therapeutics-for-covid-19-301039184.html

    PRNEWSWIRE
    13 Apr 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search